CARYN VANCE: Open Payments
NPI 1174970305 · WEST DEPTFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 14 payments from 8 companies in 2025. Trend: 2023 $387 · 2024 $179 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $37 |
| MILLICENT US INC | 2 | $36 |
| ABBVIE INC. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $15 |
Products named: SLYND, MYFEMBREE, Veozah, LILETTA, Mirena, MYOSURE TISSUE REMOVAL DEVICE, INTRAROSA, FEMLYV.
Industry payments across NJ — which companies pay providers there.
